FIBROGEN INC — Director's Dealing 2016

Feb 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-02-16

Reporting Person: VALONE FRANK H MD (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-16	Common Stock	M	2492	$2.90	Acquired	99332	Direct
2016-02-16	Common Stock	M	8258	$3.50	Acquired	107590	Direct
2016-02-16	Common Stock	S	10750	$18.4133	Disposed	96840	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-16	Stock Option (Right to Buy)	$2.90	M	2492	Disposed	2020-06-09	Common Stock (2492)	Direct
2016-02-16	Stock Option (Right to Buy)	$3.50	M	8258	Disposed	2021-06-07	Common Stock (8258)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4000	Indirect

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.

F2: The shares were sold at prices between $18.0122 and $18.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Twenty percent of the shares subject to each option vests on the first anniversary of the vesting commencement date and 80% of the shares subject to each option vests in 16 substantially equal quarterly installments thereafter over for the following four years.

F4: Fully vested.